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Abstract
Objective To determine the prevalence, impact, and stability of different
subtypes of headache in a 30 year prospective follow-up study of a
general population sample.
Design Prospective cohort study.
Setting Canton of Zurich, Switzerland.
Participants 591 people aged 19-20 from a cohort of 4547 residents of
Zurich, Switzerland, interviewed seven times across 30 years of follow-up.
Main outcome measures Prevalence of headache; stability of the
predominant subtype of headache over time; and age of onset, severity,
impact, family history, use of healthcare services, and drugs for headache
subtypes.
Results The average one year prevalences of subtypes of headache
were 0.9% (female:male ratio of 2.8) for migraine with aura, 10.9%
(female:male ratio of 2.2) for migraine without aura, and 11.5%
(female:male ratio of 1.2) for tension-type headache. Cumulative 30 year
prevalences of headache subtypes were 3.0% for migraine with aura,
36.0% for migraine without aura, and 29.3% for tension-type headache.
Despite the high prevalence of migraine without aura, most cases were
transient and only about 20% continued to have migraine for more than
half of the follow-up period. 69% of participants with migraine and 58%
of those with tension-type headache manifested the same predominant
subtype over time. However, the prospective stability of the predominant
headache subtypes was quite low, with substantial crossover among
the subtypes and no specific ordinal pattern of progression. A gradient
of severity of clinical correlates and service use was present across
headache subtypes; the greatest effect was for migraine with aura
followed by migraine without aura, and then tension-type headache and
unclassified headaches.
Conclusions These findings highlight the importance of prospective
follow-up of people with headache. The substantial longitudinal overlap
among subtypes of headache shows the developmental heterogeneity
of headache syndromes. Studies of the causes of headache that apply
diagnostic nomenclature based on distinctions between discrete
headache subtypes may not capture the true nature of headache in the
general population.
Introduction
A substantial body of international research documents the high
prevalence and serious functional impairment associated with
migraine.1 The rates of migraine and other subtypes of headache
are remarkably similar across the world, with aggregate one
year prevalence estimates of 10% for migraine and 38% for
tension-type headache in adults.2 Migraine with aura is less
common, with a lifetime prevalence of 2.0-2.3%.3 4 Severe
headaches and migraine not only have a substantial effect on
the affected person but also have major economic impact as a
result of medical expenses and employers’ costs.5 For example,
the annual direct medical cost attributable to migraine in the
United States was estimated at $1bn (£0.61bn; €0.7bn) in 1999.6
Despite the large body of cross sectional studies on the
prevalence and correlates of migraine, prospective research
from community samples that provides information on the
incidence, stability, and course of migraine in adults is lacking.
Three prospective community surveys of adults and one of
children have reported incidence data,7-10 but the longitudinal
course of specific headache subtypes in adults has been studied
in only one 12 year prospective study of a community sample
with a single follow-up interview of adults ages 25-64 in
Denmark.11 This study reported substantial longitudinal overlap
between migraine and tension-type headache and worse long
term outcome in terms of severity and recurrence among people
with coexistingmigraine and tension-type headache.11 In contrast
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to the limited number of prospective studies of adults with
migraine, several long term follow-up studies of school based
and clinical samples of specific childhood headache subtypes
have been done.12-14 In a 40 year follow-up of a sample of
Swedish schoolchildren with headache, Bille found that about
30% of those with childhood headaches developed chronic
headache in adulthood, 20% had intermittent attacks, and 50%
no longer reported headaches in adulthood.14 Similar proportions
have been found in follow-up studies of adults with migraine.11
Our study provides the first long term prospective study of
ICHD-2 (International Classification of Headache Disorders,
second edition) defined subtypes of headache in a community
sample with multiple in-person interviews over a 30 year
follow-up period. The objectives of this paper are to present
estimates of the prevalence of common headache subtypes in
young adults as they progress through early tomiddle adulthood;
to examine the stability of the predominant headache subtypes
over time; and to evaluate the course, impact, use of healthcare
services, and severity of common headache subtypes.
Methods
Setting and participants
The Zurich Cohort Study comprises a cohort of 4547 people
(2201men; 2346 women) representative of the canton of Zurich
in Switzerland in 1978. At that time, the male participants were
19 years old (at mandatory conscription) and the female
participants were 20 years old (complete electoral register). The
response rate for men was 99.7%. Women were identified at
the age of 20 by the complete electoral register; half of the
women chosen randomly received mailed questionnaires, and
75% of them responded. Binder and colleagues have presented
details of the original study aims and sampling procedures.15
Briefly, the goal of the study was to examine the prevalence,
course and outcome, impairment, and overlap among minor
psychological disturbances and somatic syndromes in a sample
from the general population. A screening scale for physical and
emotional symptoms, the Symptom Checklist 90-R,16 was
administered to prospective study participants. To enrich the
probability of psychiatric syndromes, a stratification procedure
based on over-sampling of those whose score exceeded the 85th
centile of the Symptom Checklist 90-R global severity index
score was applied as described by Dunn.17 In total, 591
participants (292 men, 299 women) were selected for interview.
Two thirds of the interview sample comprised high scorers and
one third were randomly selected from the remainder of the
initial sample (global severity index scores below the 85th
centile). The prevalence estimates reported at each wave of the
study were weighted to yield unbiased population estimates, as
described by Eich and Rössler.18 19
The interview sample had face to face interviews at ages 21,
23, 28, 30, 35, 41, and 50 years for women; men were one year
younger at all interviews (fig 1⇓). The entire cohort was
contacted at each wave irrespective of participation at the
previous interview wave. Over 30 years, 43% of the cohort
participated in all seven interviews, 55% in six interviews, 66%
in five interviews, 75% in four interviews, 83% in three
interviews, and 91% in at least two interviews. On average,
about 10% of the participants dropped out at each interview
wave. Previous analyses showed that those who dropped out
did not differ significantly from those who continued to
participate with respect to psychiatrically relevant demographic
characteristics.18We further analysed differences in participation
rates by sampling group (high v low global severity index
scorers), sex, and headache status at study entry by subgroups
used in longitudinal analyses. We found no significant
differences by risk group, sex, or headache status in these
subgroups.
Measures
Medical residents and clinical psychologists with extensive
clinical training administered the Structured Psychopathological
Interview and Rating of the Social Consequences for
Epidemiology (SPIKE), with modules for psychiatric and
somatic disorders, in the participants’ homes.20 Screening probes
based solely on the major phenomenological features of each
syndrome (such as depressed, irritable, sad mood) were
administered for each diagnostic category. Separate modules
covered the descriptive phenomenology of psychiatric
syndromes including depression, fears/phobias, panic attacks,
generalised anxiety, hypomania, obsessive-compulsive disorder,
eating behaviours, post-traumatic stress, behaviour problems,
suicidality, and alcohol, tobacco, and drug use. The successive
versions of SPIKE have enabled application of the diagnostic
criteria for DSM-III (Diagnostic and Statistical Manual of
Mental Disorders, third edition), DSM-III-R, and DSM-IV.21-23
Interviews included many demographic and social status
measures, some at only one interview and others at multiple
interviews. Other measures such as personality traits, social
supports, life events, and quality of life were also included.
Headache symptoms and disorders
The interview also assesses several somatic syndromes,
including insomnia, headache, gastrointestinal symptoms,
cardiovascular symptoms, respiratory symptoms, menstrual
symptoms, and sexual syndromes. The entry question for the
headache section inquired about whether the participant had
had headaches or migraine during the previous 12 months
(“Have you suffered from headaches or migraine during the
past 12 months?” or, in German, “Haben Sie in den letzten 12
Monaten Kopfschmerzen oderMigräne gehabt?”). If the answer
was positive, the entire headache module was administered. The
key phenomena included symptoms (such as nausea, vomiting,
anorexia, diarrhoea, sensitivity to light, sensitivity to noise,
sensitivity to smell, difficulty thinking, fatigue); prodrome (13
features of aura, then the timing and duration with respect to
headache); characteristics of headache (quality and location of
the pain); severity (from mild to extreme); effect on work;
location (unilateral, moving from one side to the other);
precipitating factors (12 situations, triggers);
frequency/duration/number and timing of headaches and
headache episodes during previous year; work/social impairment
(analogue and categorical ratings); and treatment (type of
specialist, specific drug(s), over the counter drugs). These
questions were then followed by a section that was completed
by all participants, including those with headache during the
previous 12 months, about 12 symptoms of headaches during
the interim period and treatment for headaches in each of the
years since the previous interview.
We assessed the impact of headache with dimensional analogue
measures of distress and work impairment and the number of
days in the previous year with headaches. We also examined
treatment contacts and prescribed and non-prescribed drug use.
Irrespective of whether the respondent confirmed the presence
of headaches during the previous year, we collected a history
of headaches and treatment for headache in the years between
the interviews. We also created a cumulative variable for the
number of years of the 30 year study period that the person
experienced headaches, as well as treatment for headaches. The
family history of headache and treatment for headache among
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parents and siblings enumerated individually was collected at
two of the interviews.
Sufficient information on symptoms was available for us to
ascertain the criteria of the ICHD-2 for migraine with aura,
migraine without aura, and tension-type headache from the last
five waves of the study. Most of the ICHD-2 criteria for
migraine without aura were also collected at the first two study
interviews, but the interview did not include all of the criteria
for aura. However, this community survey included no physical
or neurological examination as required by the ICHD-2.
Experienced neurologists (HI and SK) reviewed the diagnostic
criteria for the specific subtypes of headache across all the study
interviews.24 25Merikangas et al have reported previous findings
on headache in the Zurich Study.24Because many of the ICHD-2
criteria for migraine and tension-type headache are mutually
exclusive, participants could have only one specific subtype at
each time point.
Statistical analysis
Prevalence
The analysis includes both 12month and cumulative prevalence
rates. Cumulative rates are based on the 12 month prevalences
across the seven interviews as the cohort progressed from ages
20 to 50. We used the Kaplan-Meier product limit method to
calculate non-parametric estimates of the cumulative incidence
of migraine.
Impact and clinical correlates
We used analysis of variance to compare the means of severity,
work impairment, and duration of headache/treatment among
headache subtypes. We used Duncan’s test to evaluate multiple
comparisons. We used logistic regression to investigate the
associations between consultation/treatment/drug and headache
groups while controlling for sex.
Stability and crossover
To examine the stability, or extent to which participants manifest
the same predominant headache subtype over time, we examined
the proportions of participants whomet the criteria for the same
predominant subtype of headache and those who manifested
combinations of the three major subtypes. For these analyses,
we included a subset of people who had participated in at least
four interviews and who had a diagnosis of one of the primary
headache subtypes in at least one interview. We also evaluated
the longitudinal stability of the predominant headache subtypes
across 30 years by selecting people with migraine and
tension-type headache in at least one of the first three waves
and assessed the proportion who met all combinations of
subtypes across the 30 year follow-up. We used SAS 9.2 for all
the analyses. We included all available information in the
analyses, so participants with partial data were included. We
did not impute missing values.
Results
Prevalence
Table 1⇓ shows the total and sex specific weighted rates of
headache subtypes across 30 years. The average one year
prevalence of migraine with aura was 0.9%, with a total
prevalence of 3.0% (3.9% in women; 2.1% in men). The
weighted prevalences of migraine without aura ranged from
8.3% to 14.8% with a median of 10.1%. The total prevalence
of migraine without aura was 36.0%, with a female specific rate
of 50.7% and a male specific rate of 20.7%. The cumulative
lifetime prevalence of tension-type headache was 29.3%; one
year prevalences ranged from 5.7% to 19.4 % across the 30 year
follow-up, with a median of rate of 8.5%. The average
prevalence of daily headache was about 1%. The prevalence of
migraine without aura tended to decrease over time, whereas
the prevalence of tension-type headache tended to increase in
the 20s and 30s, peaking at age 40. Men had greater cumulative
prevalences of tension-type headache, whereas women had
greater rates of migraine with and without aura.
Figure 2⇓ shows the sex specific cumulative survival analysis
of the incidence of migraine across the 30 year study. Women
had higher incidences and a steeper increase in onset of migraine
than did men across the entire follow-up period. Incidence in
men levelled off at age 35, whereas that in women continued
to increase to age 50.
Impact and clinical correlates
Table 2⇓ shows the clinical correlates and impact associated
with the various subtypes of headache. A decreasing gradient
of levels of distress, impairment, and duration by severity of
headache subtype can be seen. People with migraine with aura
had the greatest level of distress (81.1), followed by 70.0 for
migraine without aura, 47.4 for tension-type headache, and 45.4
for other headache. A similar decreasing gradient emerged for
the analogue rating of work impairment: 65.9 for migraine with
aura, 60.8 for migraine without aura, 39.5 for tension-type
headache, and 29.1 for other headache. Participants with
migraine with aura had significantly greater numbers of years
with migraine than did those without aura, but they had
comparable levels of distress, work impairment, number of days
a year with headache, and proportion of years treated. Migraine
was associated with greater levels of severity and treatment
indicators than was tension-type headache.
Table 2⇓ also shows the percentage of years from the start of
the study in which the respondents had headaches. These ratings
comprise a combination of the prospective interviews and
retrospective inter-interview intervals. The average proportion
of time that participants with the various subtypes of headache
reported that they had symptoms was 86.7% (SE 3.8%) for
migraine with aura, 75.6% (1.5%) for migraine without aura,
55.6% (2.3%) for tension-type headache, and 33.9% (2.1%) for
other headache. Estimates of the number of days a year with
headache collected at the last three interviews were higher for
migraine with and without aura (27.4 (6.7) and 33.7 (3.7)) than
for tension-type headache (15.5 (1.8)) and other headache (12.1
(3.6)). A similar gradient across headache subtypes emerged
for family history of headaches. Ninety-four per cent of
participants withmigraine with aura, 75% of those withmigraine
without aura, and 72% of those with tension-type headache
reported a parental history of headaches, and 70%, 34%, and
36% reported a history of headaches in their siblings.
Table 3⇓ shows the patterns of treatment and drug use by
subtypes of headache. A similar decreasing gradient with
decreasing severity of headache subtype emerged for all of the
service measures including treatment, consultation with a
physician, and prescribed and non-prescribed drug use. Sixty-six
per cent of participants with migraine with aura reported any
treatment, and 43% had consulted a physician, compared with
57% and 36% among those with migraine without aura. Only
a minority of people with tension-type headache or unclassified
headache reported treatment or medical consultation.
Most participants with any of the headache subtypes used drugs
(82% for migraine with aura, 78% for migraine without aura,
60% for tension-type headache, and 14% for other headache).
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We also found a significant difference between headache
subtypes in the proportion of people who had used prescription
drugs, which ranged from 40% of those with migraine with aura
to less than 1% of those with other headache.
Stability and crossover
Figure 3⇓ shows the longitudinal stability of the predominant
headache subtype for participants who met criteria for either
migraine or tension-type headache at least once and participated
in four or more interviews across the study period. Of those
with migraine or tension-type headache at any interview, 0.6%
had migraine with aura and tension-type headache, 24.6% had
migraine without aura only, and 36.4% had tension-type
headache only as the predominant headache subtype across the
entire study period. About 7% met criteria for migraine both
with and without aura, and 31.5% had both migraine and
tension-type headache.
Table 4⇓ shows the number of interviews at which participants
with either migraine or tension-type headache met criteria for
that same predominant subtype across 30 years of follow-up.
We did these analyses in those who had participated in four or
more interviews across the follow-up period to enable analysis
of stability of subtype. Forty-nine per cent of those with
migraine (with or without aura) met criteria for migraine only
once, 16% continued to meet criteria twice, 15% met criteria at
three interviews, and only 21% met criteria at four or more
interviews. Most people with migraine with aura (62%) met
criteria at only one interview, 20% met them twice, and only
17%met criteria at three interviews. The stability of tension-type
headache also tended to diminish over time: 23%, 15%, and 7%
met criteria at two, three, and four or more subsequent
interviews.
Figure 4⇓ shows the longitudinal stability of migraine and
tension-type headache by the predominant headache subtype
among participants with either headache subtype at any of the
first three interviews (1979, 1981, or 1986) across the 30 year
follow-up. Sixty-nine per cent of those with migraine continued
to have migraine either alone or in combination with another
subtype of headache across the follow-up, whereas 58% of those
with tension-type headache continued to manifest that subtype.
Twelve per cent of people with migraine and 12% of those with
tension-type headache manifested only that subtype.
Approximately 19% of those with migraine developed
tension-type headache without migraine across the follow-up,
and 22% of those with tension-type headache developed
migraine alone across the follow-up. Nearly twice as many
people with tension-type headache (20%) as with migraine
(12%) by the age of 28 ceased to meet criteria for a specific
headache subtype during the remainder of the follow-up.
Discussion
The main findings of this prospective follow-up study of a
community sample are that, firstly, the cumulative 30 year
prevalence rates of subtypes of headache are substantially greater
than those derived from cross sectional and retrospective studies
of headache; however, most cases were transient and only about
20% continued to have migraine for more than half of the
follow-up period. Secondly, the high levels of subjective
distress, work impairment, and disability due to headache among
people with migraine confirm retrospective research on the
dramatic impact of migraine on people’s lives. On average,
people with migraine had headaches for one month a year for
24 of the 30 years of the follow-up period. Thirdly, most people
tended to have multiple headache subtypes across the lifespan,
with no pattern of temporal order of progression. Most (87%)
of those with migraine during the first decade of the study met
criteria for another subtype or no specific subtype (with or
without migraine) during the 20 years of follow-up. Likewise,
84% of those with tension-type headache presented with
migraine or another or no specific headache subtype across the
follow-up. In fact, only two people manifested migraine with
aura alone across the entire follow-up period. Fourthly, we found
increasing levels of clinical severity and consequences of
headaches across headache subtypes ranging from undiagnosed
headache through tension-type headache and migraine without
aura to migraine with aura, suggesting an underlying continuum
of severity of headache subtypes.
Comparison with other studies
Prevalence
The cumulative rates of migraine and tension-type headache
among young adults in this study of 36.0% for migraine without
aura, 29.3% for tension-type headache, and 3% for migraine
with aura were similar to aggregated international estimates
from previous population based studies of headache subtypes.2 4
However, the higher cumulative incidence of migraine from
our prospective data compared with previous estimates based
on retrospective data highlights the serious problem of
under-reporting at follow-up of people with a history of migraine
without persistence and the particularly poor retrospective recall
of aura.11 14 Finally, the prevalence of migraine tended to peak
somewhat earlier in men than in women, with increasing
incidence throughout early adult life, confirming the results of
prospective studies of children.10 12 14
Impact and clinical correlates
The high levels of subjective distress, work impairment, and
disability due to headache among people with migraine support
the international evidence that migraine is one of the top 10
leading causes of disability worldwide.26 27 Irrespective of
subtype of headache, we found that people with migraine
reported an average of 25 days a year with migraine, indicating
that they spend nearly one month a year with symptoms of
headache. These findings reinforce recent calls for increased
support for research on migraine to identify potential targets for
prevention and intervention.28
Stability and crossover
One of the most important findings from this study was the
substantial magnitude of overlap between the predominant
subtypes of headache that occurred at each interview. Nearly
all (84%) of the participants with migraine with aura at one or
more interviews also reported migraine without aura at another
interview, and nearly half of those with migraine without aura
or with tension-type headache also had the other subtype
longitudinally. Patterns of overlap in headache subtypes were
quite similar to the findings of follow-up studies of clinical and
population based samples of children and adults.11-14 A nearly
identical pattern of bi-directional crossover between migraine
and tension-type headache of 20-25% was reported in a seven
year follow-up study of a clinical sample of children and
adolescents.13However, our study is the first to do simultaneous
follow-up of all three common subtypes of headache.
Despite the lack of longitudinal stability of the predominant
headache subtype and the large proportion of people in whom
migraine is time limited, about 21% of those with migraine
(with or without aura) and 7% of those with tension-type
headache continued to have headaches for more than half of the
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follow-up period. These findings are remarkably similar to those
of the Danish follow-up study that reported remission in about
40-45% of people with previous headaches, intermittent
headache in 38%, and chronic severe headache in 20%.11
The substantial overlap across headache subtypes coupled with
the gradient of the magnitude of distress, impairment, family
history, and service use across the subtypes suggests that
migraine and tension-type headache may share some common
causative factors. However, evidence for a spectrum of subtypes
of headache has been inconsistent.29-31 Although some evidence
exists for specificity of familial transmission of migraine with
and without aura and tension-type headache,32 33 the results of
several twin studies show equal heritability of combinations of
headache subtypes and symptoms,34-36 and others support an
underlying continuum of features of headache with different
subtypes distinguished by severity rather than by qualitative
features.37 38 A clear-cut gradient of severity exists across
headache subtypes from migraine with aura to tension-type
headache in terms of clinical correlates, severity, treatment, and
impact. However, the lack of a unidirectional pattern of onset
of tension-type headache and migraine among people who
exhibited both subtypes over time suggests that tension-type
headache and migraine do not represent progressively more
severe manifestations of the same underlying continuum of
severity.31
Strengths and limitations
This study is the longest prospective follow-up to date of the
major subtypes of headache in a population based sample of
young adults as they pass through the peak period of onset and
progression of headaches. Other strengths include the use of
direct in-person interviews that approximated ICHD-2 criteria
for headache syndromes; inclusion of extensive information
about non-criterial symptoms, clinical correlates, and impact
of headaches; and multiple assessments across the follow-up
period rather than only one baseline and one follow-up
assessment as used in previous studies.
This study also has several limitations. Firstly, despite the
prospective design, we could not capture incident cases that
occurred before the age of 18. Secondly, the findings may not
be generalisable to other countries owing to the restricted
ethnicity and age of this cohort, as well as unique treatment
patterns in Switzerland.5 Thirdly, we had to approximate the
ICHD-2 criteria at the first two interviews because we included
the full criteria only at the last five interviews of the study and
no physical or neurological examinations were done in this
population based study. Fourthly, we did not classify more than
one headache subtype at each interview, so the lack of stability
may have been overestimated among people who simultaneously
met criteria for both migraine and tension-type headache at
several interviews.
Conclusions and implications
This study highlights the importance of prospective research in
studying the developmental course and consequences of
headache syndromes. The findings have important implications
for health policy and for the clinical care, classification, and
study of migraine and other headaches. Firstly, our findings
clearly show the high prevalence and magnitude of disability
associated with these headache syndromes across young to
middle adulthood in the general population. Secondly, clinical
evaluation and treatment of headache necessarily relies on
retrospective recall that has been shown to be highly unreliable.
Clinicians should attempt to obtain maximal information on the
history, including ancillary information where possible, rather
than relying on the clinical presentation in treatment decision
making.39 A “person based” rather than a “headache based”
approach may provide a more valid depiction of headache for
both treatment and studies of the causes of headache. Thirdly,
the high frequency of longitudinal crossover of the predominant
subtype of headache suggests that the distinction between
discrete headache subtypes in the ICHD-2 may not provide an
accurate representation of the developmental manifestations of
headache in general population samples. The lifetime
heterogeneity of expression of headache subtypes is an important
impediment to research into the causes of headaches, such as
genetic studies that rely on lifetime categorical classification of
affected status. Similar to the emerging trend in the classification
of mood disorders,40 our data provide evidence for a spectrum
of expression of headache characterised by a cluster of core
symptoms independent of recurrence, duration, and severity.
Research into causes of headache may benefit from a more
descriptive empirical approach that captures the protean
manifestations of headache across life’s developmental stages.41
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Tables
Table 1| Sex specific one year weighted rates (percentages) of mutually exclusive headache subtypes across 30 years (n=591)
No headacheOther headacheTension-type headacheMigraine without auraMigraine with auraYear and sex
1979:
40.843.25.410.6–Male
22.846.811.618.8–Female
31.745.08.514.8–Total
1981:
64.524.56.24.8–Male
40.734.65.219.5–Female
52.429.65.712.3–Total
1986:
65.522.45.75.50.9Male
48.328.011.111.11.5Female
56.725.38.58.31.2Total
1988:
66.319.28.45.11.0Male
51.423.18.515.02.0Female
58.821.28.410.11.5Total
1993:
61.510.121.36.90.2Male
52.015.414.716.61.3Female
56.612.818.011.80.8Total
1999:
63.812.916.07.20.1Male
46.815.622.812.91.9Female
55.214.319.410.11.0Total
2008:
74.38.59.57.60.1Male
59.016.513.810.40.3Female
66.512.611.79.00.2Total
Cumulative:
16.326.834.120.72.1Male
6.614.224.650.73.9Female
11.320.429.336.03.0Total
Average 1 year:
62.220.110.46.80.5Male
45.525.512.515.11.4Female
53.723.011.510.90.9Total
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Table 2| Clinical correlates and impact by mutually exclusive headache subtypes. Values are weighted mean (SE, range) unless stated
otherwise
Other headache
(n=129)
Tension-type headache
(n=153)
Migraine without aura
(n=224)
Migraine with aura
(n=26)Total (n=532)NoImpact/correlates
45.4 (4.4, 0-100)§47.4 (2.2, 0-100)§70.0 (1.8, 0-100)‡81.1 (4.1, 40-100)‡58.9 (1.4, 0-100)462Distress (0-100)
29.1 (4.6, 0-100)§39.5 (2.6, 0-100)§60.8 (2.3, 0-100)‡65.9 (5.1, 10-100)‡49.4 (1.7, 0-100)391*Work impairment (0-100)
33.9 (2.1, 3.2-100)55.6 (2.3, 3.2-100)¶75.6 (1.5, 9.7-100)§86.7 (3.8, 48.4-100)‡59.6 (1.3, 3.2-100)532Years with symptoms
1978-2008 (%)
1.2 (0.4, 0-50)§1.9 (0.4, 0-35.5)§11.4 (1.2, 0-100)‡9.3 (2.5, 0-58.1)‡5.8 (0.6, 0-100)532Years treated 1978-2008
(%)
12.1 (3.6, 0-60)§15.5 (1.8, 1-200)‡§33.7 (3.7, 2-300)‡27.4 (6.7, 2-200)‡§24.8 (2.1, 0-300)345†Days/year with headache
(1993, 1999, and 2008)
Family history (% (SE)):
54.5 (5.6)¶72.4 (4.0)§75.1 (3.1)§93.5 (4.9)‡71.6 (2.2)428Parents
36.7 (5.4)§35.6 (4.3)§34.0 (3.4)§69.9 (9.2)‡36.6 (2.3)428Siblings
58.7 (4.8)§86.7 (2.9)‡84.5 (2.5)‡96.1 (3.9)‡80.6 (1.8)480Either
*Some female participants did not work.
†Based on information from 1993, 1999, and 2008 interviews.
‡§¶Means/rates with same symbol are not significantly different (Duncan test).
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Table 3| Weighted rates of treatment and drug use by mutually exclusive headache subtypes
Odds ratio (95% CI)*Weighted rate (% (No))
Treatment/drugs
Tension-type
headache v other
headache
Migraine v
tension-type
headache
Migraine with
aura v migraine
without aura
Other
headache
(n=129)
Tension-type
headache
(n=153)
Migraine
without aura
(n=224)
Migraine with
aura (n=26)
Total
(n=532)
2.5 (1.7 to 3.8)†3.0 (2.3 to 3.8)†1.6 (0.99 to 2.5)6.0 (11)12.9 (17)36.3 (77)43.4 (13)23.0 (118)Consulted doctor
3.9 (2.8 to 5.5)†2.8 (2.3 to 3.5)†1.5 (0.9 to 2.5)8.8 (16)28.0 (41)57.4 (128)65.7 (20)36.6 (205)Treatment
Drug:
–‡3.8 (2.8 to 5.1)†1.8 (1.1 to 2.9)†0.2 (1)8.5 (14)27.3 (56)39.5 (10)15.1 (81)Prescribed
9.5 (7.1 to 12.7)†2.1 (1.7 to 2.6)†1.6 (0.9 to 3.0)13.3 (19)58.5 (92)72.6 (165)81.6 (22)54.5 (298)Non-prescribed
9.7 (7.3 to 12.9)†2.4 (1.9 to 3.0)†1.3 (0.7 to 2.3)13.5 (20)60.0 (93)77.6 (170)81.6 (22)57.1 (305)Either
*From logistic regression.
†Significant at P<0.05.
‡Only one participant in “other headache” group.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2011;343:d5076 doi: 10.1136/bmj.d5076 Page 9 of 12
RESEARCH
Table 4| Number of interviews by headache subtypes across 30 years
Total No
No (%) of interviews with same headache
Headache subtypes across 30 years ≥4321
22047 (20.5)36 (14.6)44 (15.6)93 (49.3)Migraine with or without aura*
261(1.3)3 (17.2)5 (19.7)17 (61.8)Migraine with aura†
24417 (7.0)32 (14.7)65 (23.0)130 (55.3)Tension-type headache‡
*Respondents with ≥4 interviews who had migraine with or without aura at ≥1 interview (n=220).
†Respondents with ≥4 interviews who had migraine with aura at ≥1 interview (n=26).
‡Respondents with ≥4 interviews who had tension-type headache at ≥1 interview (n=244).
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Figures
Fig 1 Sample and design of Zurich Cohort Study, 1978-2008
Fig 2 Cumulative incidence of migraine across 30 years (n=591)
Fig 3Combinations of headache subtypes across 30 years among participants who met criteria for migraine (with or without
aura) or tension-type headache at ≥1 interview and were interviewed ≥4 times across follow-up (n=346)
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2011;343:d5076 doi: 10.1136/bmj.d5076 Page 11 of 12
RESEARCH
Fig 4 Prospective stability of predominant headache subtype across 30 years among participants who met criteria for
migraine (with or without aura; top) or tension-type headache (bottom) at ages 19-20 to 27-28 and were interviewed ≥4
times across follow-up. MIG=migraine with or without aura; TT=tension-type headache
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